PGR and cancer: Based on the “structure-inherent cancer targeting” strategy, the water-soluble zwitterionic small molecule dye CA800-PR successfully showed tumor-specific targeting, NIR fluorescence imaging, and tumor-targeted therapy in an MCF-7 xenograft mouse model.